Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,298Revenue (TTM) $M10,029Net Margin (%)-22.7Altman Z-Score0.2
Enterprise Value $M35,331EPS (TTM) $-6.6Operating Margin %-5.4Piotroski F-Score4
P/E(ttm)--Beneish M-Score-3.0Pre-tax Margin (%)-23.2Higher ROA y-yN
Price/Book1.310-y EBITDA Growth Rate %18.9Quick Ratio1.1Cash flow > EarningsY
Price/Sales0.55-y EBITDA Growth Rate %87.0Current Ratio1.5Lower Leverage y-yY
Price/Free Cash Flow2.9y-y EBITDA Growth Rate %-28.5ROA % (ttm)-4.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-41.5Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M348ROIC % (ttm)-1.1Gross Margin Increase y-yN

Gurus Latest Trades with VRX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VRXLou Simpson 2016-09-30 Sold Out -2.07%$19.95 - $31.27
($25.88)
$ 15.24-41%Sold Out0
VRXPrivate Capital 2016-09-30 Add0.14%$19.95 - $31.27
($25.88)
$ 15.24-41%Add 12.73%347,368
VRXJohn Paulson 2016-09-30 Reduce-0.04%$19.95 - $31.27
($25.88)
$ 15.24-41%Reduce -1.05%18,871,000
VRXRuane Cunniff 2016-09-30 Reduce-0.03%$19.95 - $31.27
($25.88)
$ 15.24-41%Reduce -38.19%275,963
VRXChris Davis 2016-09-30 Add0.01%$19.95 - $31.27
($25.88)
$ 15.24-41%Add 0.83%7,365,210
VRXRuane Cunniff 2016-06-30 Reduce-6.1%$18.73 - $36.23
($28.28)
$ 15.24-46%Reduce -98.53%446,442
VRXGlenn Greenberg 2016-06-30 Sold Out -2.61%$18.73 - $36.23
($28.28)
$ 15.24-46%Sold Out0
VRXJohn Paulson 2016-06-30 Add1.21%$18.73 - $36.23
($28.28)
$ 15.24-46%Add 43.56%19,072,000
VRXDavid Tepper 2016-06-30 Sold Out -0.44%$18.73 - $36.23
($28.28)
$ 15.24-46%Sold Out0
VRXArnold Schneider 2016-06-30 Sold Out -0.34%$18.73 - $36.23
($28.28)
$ 15.24-46%Sold Out0
VRXLou Simpson 2016-06-30 Reduce-0.16%$18.73 - $36.23
($28.28)
$ 15.24-46%Reduce -6.31%2,427,903
VRXPrivate Capital 2016-06-30 Reduce-0.11%$18.73 - $36.23
($28.28)
$ 15.24-46%Reduce -10.14%308,142
VRXFirst Eagle Investment 2016-06-30 Reduce-0.07%$18.73 - $36.23
($28.28)
$ 15.24-46%Reduce -74.53%380,900
VRXChris Davis 2016-06-30 Add0.01%$18.73 - $36.23
($28.28)
$ 15.24-46%Add 0.89%7,304,762
VRXJoel Greenblatt 2016-06-30 Sold Out $18.73 - $36.23
($28.28)
$ 15.24-46%Sold Out0
VRXGlenn Greenberg 2016-03-31 Reduce-17.01%$26.3 - $102.4
($74.84)
$ 15.24-80%Reduce -67.46%2,034,281
VRXRuane Cunniff 2016-03-31 Reduce-2.93%$26.3 - $102.4
($74.84)
$ 15.24-80%Reduce -14.32%30,308,449
VRXSteve Mandel 2016-03-31 Sold Out -2.53%$26.3 - $102.4
($74.84)
$ 15.24-80%Sold Out0
VRXBill Ackman 2016-03-31 Add1.48%$26.3 - $102.4
($74.84)
$ 15.24-80%Add 30.14%21,591,122
VRXDavid Tepper 2016-03-31 Buy 0.44%$26.3 - $102.4
($74.84)
$ 15.24-80%New holding945,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VRX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


VRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ross Thomas W. Sr.Director 2016-12-14Buy5,000$14.733.46view
Pershing Square Capital ManageDirector 2016-12-12Sell3,476,690$14.852.63view
KARABELAS ARGERIS NDirector 2016-08-11Buy4,000$24.65-38.17view
Ross Thomas W. Sr.Director 2016-06-13Buy4,000$24.4-37.54view
PAPA JOSEPH CCHAIRMAN & CEO 2016-06-10Buy202,000$24.48-37.75view
Pearson J. MichaelCEO 2015-11-05Sell1,297,399$78.48-80.58view
Farmer Ronald HaroldDirector 2015-10-21Buy1,500$181.6-91.61view
Farmer Ronald HaroldDirector 2015-08-26Buy500$220-93.07view
Farmer Ronald HaroldDirector 2015-08-21Buy1,000$224.97-93.23view
Rosiello Robert L.EVP, CFO 2015-07-31Buy7,875$254.28-94.01view

Press Releases about VRX :

Quarterly/Annual Reports about VRX:

News about VRX:

Articles On GuruFocus.com
23 Questions With Adam Strauss of Appleseed Fund Dec 28 2016 
Biotech Stocks to Watch After Senate Drug Report Dec 27 2016 
Bill Ackman Reduces Valeant Stake to Benefit Clients Dec 14 2016 
Bill Ackman Comments on Valeant Pharmaceuticals International Dec 09 2016 
24 Questions With Value Investor Jacob Taylor of the UC Davis Graduate School of Management Dec 06 2016 
Valeant, Salix, Sales Force and Asset Sales Nov 30 2016 
Ackman Sticks With Valeant as a Deleverage Story Nov 21 2016 
Valeant and Philidor After the Criminal Charges Nov 18 2016 
Lou Simpson Goes 2-for-2 in 3rd Quarter Nov 14 2016 
Bill Ackman: Valeant Diversified Pharma Business a Buffett ‘Cigar Butt’ Nov 10 2016 

More From Other Websites
Short Sellers Now Fleeing Valeant Stock Jan 17 2017
[$$] Allergan Admits to Disclosure Violations During Valeant Bid Jan 17 2017
Bill Ackman Eases Into the New Year Jan 17 2017
Mario Gabelli on Viacom: Potential Growth in the Media Sector Jan 17 2017
Pharma Stock Roundup: Trump Targets Pharma Again, Merck Up on Keytruda News Jan 13 2017
ETFs with exposure to Valeant Pharmaceuticals International, Inc. : January 12, 2017 Jan 12 2017
Is Valeant Pharmaceuticals Intl Inc (VRX) Stock Back From The Dead? Jan 12 2017
Valeant Pharmaceuticals International, Inc. – Value Analysis (NYSE:VRX) : January 12, 2017 Jan 12 2017
Trump criticism leads to falling stock prices at these Tampa employers Jan 12 2017
Deja Vu for Drug Stocks as Trump Slams Drug Pricing Again Jan 12 2017
Valeant Streamlines Portfolio with Skincare Brands Sale Jan 11 2017
Drug Stocks Tank As Trump Vows To Attack High Drug Prices Jan 11 2017
Wednesday’s Top Biopharma Movers Jan 11 2017
Valeant's CEO Tries to Pitch Wall Street On the 'New Valeant' Being Very Different Jan 11 2017
Valeant Pharmaceuticals: Now Comes the Hard Part Jan 11 2017
Valeant Pharmaceuticals: 'A Long Road to Recovery' Jan 11 2017
Latest Research Reports on Market Movers Valeant Pharmaceuticals and Chipotle Mexican Grill Jan 11 2017
Do Options Traders Know Something About Valeant Pharmaceuticals (VRX) Stock We Don't? Jan 11 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)